Evidence map›Paper›PMID 42638639›Full record

ArticleFrontiers in tuberculosis2025

Novel diagnostic test for the detection of

Gayathri Ramasubban, Joy Sarojini Michael, Richa Gupta, Kavyasri Channamaneni, Dhanabagyam Krishnan, Dev Chandran, Sven Hoffner, Pavankumar Asalapuram

Abstract read
In one paragraph

Article in Frontiers in tuberculosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gayathri RamasubbanEMPE Diagnostics Private Limited, Hyderabad, India.
Joy Sarojini MichaelDepartment of Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
Richa GuptaChristian Medical College and Hospital, Vellore, Tamil Nadu, India.
Kavyasri ChannamaneniEMPE Diagnostics Private Limited, Hyderabad, India.
Dhanabagyam KrishnanDepartment of Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
Dev ChandranEMPE Diagnostics Private Limited, Hyderabad, India.
Sven HoffnerDepartment of Global Public Health, Karolinska Institutet (KI), Stockholm, Sweden.
Pavankumar AsalapuramEMPE Diagnostics Private Limited, Hyderabad, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rapid identification of tuberculosis (TB) and its drug resistance is crucial for starting effective treatment promptly and preventing the spread of resistant Methodology: We have evaluated the performance of Results: The Conclusion: The

Indexed as

fluoroquinoloneisoniazidMDR-TBpre-XDR-TBrapid diagnosticsrifampicin

Identifiers

PMID42638639
PMCPMC13494996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.